Ocular Therapeutix earnings were -$192.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest OCUL earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$64.1M, up 32.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, OCUL reported annual earnings of -$193.5M, with 139.7% growth. The next OCUL earnings date is Aug 5, 2025.
What were Ocular Therapeutix's earnings last quarter?
On OCUL's earnings call on Invalid Date, Ocular Therapeutix (NASDAQ: OCUL) reported Q1 2025 earnings per share (EPS) of -$0.38, up 22.45% year over year. Total OCUL earnings for the quarter were -$64.05 million. In the same quarter last year, Ocular Therapeutix's earnings per share (EPS) was -$0.49.
The next OCUL earnings date is Invalid Date. Add OCUL to your watchlist to be reminded of Ocular Therapeutix's next earnings date.
Is Ocular Therapeutix profitable or losing money?
As of the last Ocular Therapeutix earnings report, Ocular Therapeutix is currently losing money. Ocular Therapeutix's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$192.71 million, a 67.19% increase year over year.
What was OCUL's earnings growth in the past year?
As of Ocular Therapeutix's earnings date in Invalid Date, Ocular Therapeutix's earnings has grown year over year. OCUL earnings in the past year totalled -$192.71 million.
What are Ocular Therapeutix's earnings expectations?
The current EPS estimate for Ocular Therapeutix's earnings report in Invalid Date is -$0.35.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.